DNA damage-induced nuclear translocation of apaf-1 is mediated by nucleoporin nup107

Cell Cycle

Volumn 14, Issue 8, 2015, Pages 1242-1251

  Jagot Lacoussiere, Léonard ^a   Faye, Audrey ^a   Bruzzoni Giovanelli, Heriberto ^a   Villoutreix, Bruno O ^a   Rain, Jean Christophe ^b   Poyet, Jean Luc ^a  

^a INSERM   (France)

^b Hybrigenics SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; NUCLEOPORIN; NUCLEOPORIN NUP107; PROTEIN P53; UNCLASSIFIED DRUG; ATM PROTEIN; ATR PROTEIN, HUMAN; CHECKPOINT KINASE 1; CISPLATIN; ISOPROTEIN; NUP107 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN KINASE; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; NUCLEAR IMPORT; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; S PHASE CELL CYCLE CHECKPOINT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL NUCLEUS; DEFICIENCY; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; RNA INTERFERENCE;

ANIMALS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE; CELL NUCLEUS; CHECKPOINT KINASE 1; CISPLATIN; DNA DAMAGE; HUMANS; MICE; NUCLEAR PORE COMPLEX PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN KINASES; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; S PHASE CELL CYCLE CHECKPOINTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84928004366     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1014148     Document Type: Article

References (35)

1. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326 (Pt 1):1-16. PMID:9337844.
2. Song Z, Steller H. Death by design: mechanism and control of apoptosis. Trends Cell Biol 1999; 9:M49-52. PMID:9337844. http://dx.doi.org/10.1016/S0962-8924(99)01670-0
3. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90:405-13. PMID:9267021; http://dx.doi.org/10.1016/S0092-8674(00)80501-2
4. Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 2008; 9:532-42; PMID:18568041; http://dx.doi.org/10.1038/nrm2434
5. Schafer ZT, Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 2006; 10:549-61; PMID:16678772; http://dx.doi.org/10.1016/j.devcel.2006.04.008
6. Benedict MA, Hu Y, Inohara N, Nunez G. Expression and functional analysis of Apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J Biol Chem 2000; 275:8461-8. http://dx.doi.org/10.1074/jbc.275.12.8461
7. Hu Y, Benedict MA, Ding L, Nunez G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-medi-ated caspase-9 activation and apoptosis. EMBO J 1999; 18:3586-95. PMID:10393175; http://dx.doi.org/10.1093/emboj/18.13.3586
8. Ferraro E, Pesaresi MG, De Zio D, Cencioni MT, Gortat A, Cozzolino M, Berghella L, Salvatore AM,Oettinghaus B, Scorrano L, et al. Apaf1 plays a pro-survival role by regulating centrosome morphology and function. J Cell Sci 2011; 124:3450-63. PMID:21984814; http://dx.doi.org/10.1242/jcs.086298
9. Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S, Pauleau AL, Rosselli F, D'Amelio M, Amendola R, et al. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell 2007; 28:624-37 PMID:18042457 http://dx.doi.org/10.1016/j.molcel.2007.09.030
10. Hausmann G, O'Reilly LA, van Driel R, Beaumont JG, Strasser A, Adams JM, Huang DC. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L). J Cell Biol 2000; 149:623-34. PMID:10791976; http://dx.doi.org/10.1083/jcb.149.3.623.
11. Ruiz-Vela A, Gonzalez de Buitrago G, Martinez AC.Nuclear Apaf-1 and cytochrome c redistribution following stress-induced apoptosis. FEBS Lett 2002; 517:133-8 PMID:12062423; http://dx.doi.org/10.1016/S00l4-5793(02)02607-8.
12. Sakai T, Liu L, Teng X, Mukai-Sakai R, Shimada H, Kaji R, Mitani T, Matsumoto M, Toida K, Ishimura K, et al. Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis. J Biol Chem 2004; 279:41131-40; PMID:15271982;http://dx.doi.org/10.1074/jbc.M402902200.
13. Besse B, Cande C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G.Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer. Clin Cancer Res2004; 10:5665-9; PMID:15355891; http://dx.doi.org/10.1158/1078-0432.CCR-04-0415.
14. Robinson HM, Jones R, Walker M, Zachos G, Brown R, Cassidy J, Gillespie DA. Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluoro-uracil. Oncogene 2006; 25:5359-69; PMID:16619043; http://dx.doi.org/10.1038/sj.onc.1209532.
15. Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001; 21:4129-39; PMID:11390642; http://dx.doi.org/10.1128/MCB.21.13.4129-4139.2001
16. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell 2009; 138:838-54; PMID:19737514;http://dx.doi.Org/10.1016/j.cell.2009.08.021.
17. Kim J, Parrish AB, Kurokawa M, Matsuura K, Freel CD, Andersen JL, Johnson CE, Kornbluth S. Rsk-mediated phosphorylation and 14-3-3varepsilon binding of Apaf-1 suppresses cytochrome c-induced apoptosis. EMBO J 2012; 31:1279-92; PMID:22246185;http://dx.doi.org/10.1038/emboj.2011.491.
18. Martin MC, Allan LA, Lickrish M, Sampson C, Morrice N, Clarke PR. Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c. J Biol Chem 2005; 280:15449-55; PMID:15703181;http://dx.doi.org/10.1074/jbc.M414325200.
19. McGahren-Murray M, Terry NH, Keyomarsi K. The differential staurosporine-mediated G1 arrest in normal versus tumor cells is dependent on the retinoblastoma protein. Cancer Res 2006; 66:9744-53; PMID:17018634; http://dx.doi.org/10.1158/0008-5472.CAN-06-1809
20. Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. OncoTargets Ther 2014; 7:1015-23; PMID:24959088; http://dx.doi.org/10.2147/OTT.S60114
21. Radu A, Blobel G, Wozniak RW. Nup107 is a novel nuclear pore complex protein that contains a leucine zipper. J BiolChem 1994; 269:17600-5; PMID:8021268.
22. Boehmer T, Enninga J, Dales S, Blobel G, Zhong H.Depletion of a single nucleoporin, Nup107, prevents the assembly of a subset of nucleoporins into the nuclear pore complex. Proc Natl Acad Sci USA 2003; 100:981-5; PMID:12552102; http://dx.doi.org/10.1073/pnas.252749899
23. Walther TC, Alves A, Pickersgill H, Loiodice I, Hetzer M, Galy V, Hulsmann BB, Kocher T, Wilm M, Allen T, et al. The conserved Nup107-160 complex is critical for nuclear pore complex assembly. Cell 2003; 113:195-206; PMID:12705868; http://dx.doi.org/10.1016/S0092-8674(03)00235-6.
24. Tran EJ, Wente SR. Dynamic nuclear pore complexes: life on the edge. Cell 2006; 125:1041-53; PMID:16777596; http://dx.doi.org/10.1016/j. cell.2006.05.027
25. Gonzalez-Aguilera C, Askjaer P. Dissecting the NUP107 complex: multiple components and even more functions. Nucleus 2012; 3:340-8; PMID: 22713280; http://dx.doi.org/10.4161/nucl.21135.
26. Nagai S, Dubrana K, Tsai-Pflugfelder M, Davidson MB, Roberts TM, Brown GW, Varela E, Hediger F, Gasser SM, Krogan NJ. Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science 2008; 322:597-602; http://dx.doi.org/10.1126/science.1162790
27. Palancade B, Liu X, Garcia-Rubio M, Aguilera A, Zhao X, Doye V. Nucleoporins prevent DNA damage accumulation by modulating Ulp1-dependent sumoylation processes. Mol Biol Cell 2007; 18:2912-23; PMID:17538013; http://dx.doi.org/10.1091/mbc.E07-02-0123
28. Mondragon L, Galluzzi L, Mouhamad S, Orzaez M, Vicencio JM, Vitale I, Moure A, Messeguer A, Perez-Paya E, Kroemer G. A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis 2009; 14:182-90; PMID:19152031; http://dx.doi.org/10.1007/s10495-008-0310-x
29. Glavy JS, Krutchinsky AN, Cristea IM, Berke IC, Boehmer T, Blobel G, Chait BT. Cell-cycle-dependent phosphorylation of the nuclear pore Nup107-160 subcomplex. Proc Natl Acad Sci USA 2007; 104:3811-6; PMID:17360435; http://dx.doi.org/10.1073/pnas.0700058104
30. Kau TR, Way JC, Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev2004; 4:106-17; PMID:14732865,.
31. Sharma M, Jamieson C, Johnson M, Molloy MP, Henderson BR. Specific armadillo repeat sequences facilitate beta-catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358. J Biol Chem 2012; 287:819-31; PMID:22110128; http://dx.doi.org/10.1074/jbc.M111.299099
32. Wozniak R, Burke B, Doye V. Nuclear transport and the mitotic apparatus: an evolving relationship. Cell Mol Life Sci 2010; 67:2215-30; PMID:20372967; http://dx.doi.org/10.1007/s00018-010-0325-7.
33. Fromont-Racine M, Rain JC, Legrain P. Building protein-protein networks by two-hybrid mating strategy.Methods Enzymol 2002; 350:513-24; PMID:12073333; http://dx.doi.org/10.1016/S0076-6879(02)50982-4
34. Rigou P, Piddubnyak V, Faye A, Rain JC, Michel L, Calvo F, Poyet JL. The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation. EMBO J 2009; 28:1576-88; PMID:19387494; http://dx.doi.org/10.1038/emboj.2009.106
35. Piddubnyak V, Rigou P, Michel L, Rain JC, Geneste O, Wolkenstein P, Vidaud D, Hickman JA, Mauviel A, Poyet JL. Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients. Cell Death Differ 2007; 14:122-233; PMID:17380155; http://dx.doi.org/10.1038/sj.cdd.4402122